Hans Fritz

Hans Fritz's AcademicInfluence.com Rankings

Hans Fritz

Biology

#11452

World Rank

#14849

Historical Rank

Biochemistry

#1890

World Rank

#2031

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Hans Fritz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hans Fritz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. (1983) (419)
Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. (1986) (285)
Human β-tryptase is a ring-like tetramer with active sites facing a central pore (1998) (239)
LEKTI, a Novel 15-Domain Type of Human Serine Proteinase Inhibitor* (1999) (236)
Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. (1992) (201)
Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. (1985) (186)
Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. (1991) (181)
Ionomycin-activated Calpain Triggers Apoptosis (2002) (176)
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins (2006) (141)
Effect of human granulocytic elastase on isolated human antithrombin III. (1981) (113)
Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data. (1985) (111)
Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches. (1977) (104)
Primary structure of a Kunitz-type trypsin inhibitor from Enterolobium contortisiliquum seeds. (1996) (103)
A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. (1994) (103)
A Carboxypeptidase Inhibitor from the Medical Leech Hirudo medicinalis (1998) (96)
Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. (1986) (93)
Granulocyte proteinases as mediators of unspecific proteolysis in inflammation: a review. (1986) (92)
Protein inhibitors of cysteine proteinases. II. Primary structure of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. (1983) (87)
The complete covalent structure of hirudin. Localization of the disulfide bonds. (1985) (86)
Kininogens: More than cysteine protease inhibitors and kinin precursors. (2010) (86)
Amino-acid sequence of a coelenterate toxin: toxin II from Anemonia sulcata. (1976) (84)
Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model. (2005) (83)
Release of granulocyte proteinases during hemodialysis. (1983) (82)
Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. (1998) (82)
The human mast cell tryptase tetramer: a fascinating riddle solved by structure. (2000) (81)
The role of phagocyte proteinases and proteinase inhibitors in multiple organ failure. (1994) (74)
Papulacandins, a new family of antibiotics with antifungal activity. Structures of papulacandins A, B, C and D. (1980) (72)
Mast Cell Tryptase Degrades HDL and Blocks Its Function as an Acceptor of Cellular Cholesterol (2002) (71)
Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis. (1994) (70)
The Three-dimensional Structure of Recombinant Leech-derived Tryptase Inhibitor in Complex with Trypsin (1997) (69)
Subcellular Localization and in VivoSubunit Interactions of Ubiquitous μ-Calpain* (2003) (69)
Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. (1990) (66)
A common nomenclature for members of the tissue (glandular) kallikrein gene families. (1992) (65)
Proteinases and their inhibitors in septicemia - basic concepts and clinical implications. (1984) (64)
Inhibitors of acrosin and granulocyte proteinases from human genital tract secretions. (1976) (63)
Isolation and characterization of hirudin isoinhibitors and sequence analysis of hirudin PA. (1986) (62)
Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). (1988) (61)
[Polyvalent isoinhibitors for trypsin, chymotrypsin, plasmin and kallikreins of sea anemones (Anemonia sulcata), isolation, inhibitory behavior and amino acid composition]. (1972) (58)
Immunofluorescence studies indicate that the basic trypsin-kallikrein-inhibitor of bovine organs (Trasylol) originates from mast cells. (1979) (56)
Characterization of a Kunitz trypsin inhibitor with one disulfide bridge purified from Swartzia pickellii. (2002) (55)
Recombinant chicken egg white cystatin variants of the QLVSG region. (1992) (54)
Posttransfusion Serratia marcescens septicemia (1993) (54)
Isolation and characterization of human urinary kallikrein. (1980) (53)
[39] Human urinary kallikrein (1981) (53)
[Biochemical factors as objective parameters for assessing the prognosis in polytrauma]. (1992) (51)
Clotting and other plasma factors in experimental endotoxemia: inhibition of degradation by exogenous proteinase inhibitors. (1981) (48)
Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alpha 1-antitrypsin (alpha 1-protease inhibitor). (1981) (47)
Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration. (1988) (47)
A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex. (1997) (47)
Human Keratinocyte Cell Lines Differ in the Expression of the Collagenolytic Matrix Metallo-proteinases-1, -8, and -13 and of TIMP-1 (2000) (47)
[On a hormone dependent inhibitor of proteolytic enzymes in male accessory sex glands and in sperm]. (1965) (47)
Recent Progress on Kinins (1982) (46)
Kallikrein inhibitors. (1979) (45)
Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors. (1986) (44)
Isolation of an enzymatically active glandular kallikrein from human plasma by immunoaffinity chromatography. (1980) (43)
[27] Sperm acrosin (1976) (43)
Bdellastasin, a serine protease inhibitor of the antistasin family from the medical leech (Hirudo medicinalis)--primary structure, expression in yeast, and characterisation of native and recombinant inhibitor. (1998) (43)
Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. (1994) (43)
[47] Sperm acrosin (1981) (42)
Potential problems in designing elastase inhibitors for therapy. (1991) (41)
The primary structure of bdellin B-3 from the leech Hirudo medicinalis. Bdellin B-3 is a compact proteinase inhibitor of a "non-classical" Kazal type. It is present in the leech in a high molecular mass form. (1986) (41)
Functional phage display of leech‐derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors (1999) (41)
Multiple forms of human acrosin: isolation and properties. (1976) (40)
Identification and occurrence of mRNAs for components of the kallikrein-kinin system in human skin and in skin diseases. (1999) (39)
Plant serine proteinase inhibitors. Structure and biochemical applications on plasma kallikrein and related enzymes. (1996) (39)
Histochemical assessment of early myocardial infarction using 2,3,5-triphenyltetrazolium chloride in blood-perfused porcine hearts. (2006) (39)
Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis. (1980) (38)
Oviposition-deterring pheromone inRhagoletis cerasi L.: Purification and determination of the chemical constitution (1987) (37)
[60] Eglin: Elastase—Cathepsin G inhibitor from leeches (1981) (36)
Porcine glandular kallikreins. (1981) (36)
PHYSIOLOGIC, PHARMACOLOGIC, AND CLINICAL ASPECTS OF PROTEINASE INHIBITORS (1968) (35)
Purification and properties of boar acrosin. (1980) (35)
Effect of combined B1 and B2 kinin receptor blockade in porcine endotoxin shock. (1996) (34)
[Determination of the molecular weight of new trypsin inhibitors with the aid of sephadex gel filtration]. (1965) (32)
Sequence determination of eglin C using combined microtechniques of amino acid analysis, peptide isolation, and automatic Edman degradation. (1983) (32)
[On protease inhibitors. I. Isolation and characterization of trypsin inhibitors from dog pancreas tissue and pancreas scretion]. (1966) (32)
CHEMISTRY AND BIOCHEMISTRY OF PROTEINASE INHIBITORS FROM MAMMALIAN TISSUES (1968) (32)
Human plasma kallikrein and tissue kallikrein binding to a substrate based on the reactive site of a factor Xa inhibitor isolated from Bauhinia ungulata seeds. (1999) (32)
Acid-stable proteinase inhibitors from human seminal plasma. (1976) (31)
Broad-specificity inhibitors from sea anemones. (1976) (30)
The hypotensive response to des-Arg9-bradykinin increases during E. coli septicemia in the pig. (1989) (29)
[61] The broad-specificity proteinase inhibitor 5 II from the sea anemone Anemonia sulcata (1981) (29)
Determination of thrombin-hirudin complex in plasma with an enzyme-linked immunosorbent assay. (1991) (29)
Increased intracellular calpain detection in experimental focal cerebral ischemia. (1999) (29)
Structure of inter-alpha-inhibitor (inter-alpha-trypsin inhibitor) and pre-alpha-inhibitor: current state and proposition of a new terminology. (1990) (28)
A new acrosin inhibitor from boar spermatozoa. (1982) (28)
Interaction of human sperm acrosomal proteinase with human seminal plasma proteinase inhibitors. (1973) (28)
Multiple forms of boar acrosin and their relationship to proenzyme activation. (1976) (28)
Subcellular localization and in vivo subunit interactions of ubiquitous mu-calpain. (2003) (28)
Inhibition of plasma kallikrein with aprotinin in porcine endotoxin shock. (1993) (28)
Enzymic characterization of rabbit blastocyst proteinase with synthetic substrates of trypsin-like enzymes. (1979) (27)
Bauhinia serine proteinase inhibitors: effect on factor X, factor XII and plasma kallikrein. (1996) (27)
Validity of the elastase assay in intensive care medicine. (1989) (27)
Studies for revealing a possible sensitization to hirudin after repeated intravenous injections in baboons. (1991) (27)
Pathobiochemical mechanisms in inflammation (1989) (27)
Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxaemia): biochemical, pathophysiological and therapeutic aspects. (1979) (27)
A convenient large-scale preparation of high molecular weight kininogen from human plasma. (1981) (27)
Some Characteristics of Highly Purified Boar Sperm Acrosin (2009) (27)
Reduction of myocardial infarction by calpain inhibitors A-705239 and A-705253 in isolated perfused rabbit hearts (2004) (26)
Trypsin-plasmin inhibitors (bdellins) from leeches. (1976) (26)
Inhibition of porcine glandular kallikreins by structurally homologous proteinase inhibitors of the Kunitz (Trasylol) type. Significance of the basic nature of amino acid residues in subside positions for kallikrein inhibition. (1979) (26)
Purification and primary structure determination of two Bowman-Birk type trypsin isoinhibitors from Cratylia mollis seeds. (2006) (26)
[On protease inhibitors. II. Isolation and characterization of protease inhibitors from the neck of the pancreas of several vertebrates and man]. (1966) (26)
A Kunitz-type glycosylated elastase inhibitor with one disulfide bridge. (2006) (26)
Aprotinin concentrations effective for the inhibition of tissue kallikrein and plasma kallikrein in vitro and in vivo. (1989) (26)
Highly purified acrosomal proteinase (boar acrosin): isolation by affinity chromatography using benzamidine-cellulose and stabilization. (1973) (26)
[Human acrosin: kinetics of the inhibition by inhibitors from human sera]. (1972) (26)
Proteinase inhibitors from boar seminal plasma. (1976) (26)
Characterization of Two Proteinase Inhibitors from Human Seminal Plasma and Spermatozoa (1974) (25)
Purification and characterization of a chicken egg white cystatin variant expressed in an Escherichia coli pIN-III-ompA system. (1991) (25)
Disturbances of selected plasma proteins in hyperdynamic septic shock (1982) (24)
Elastases from human and canine granulocytes, II. Interaction with protease inhibitors of animal, plant, and microbial origin. (1977) (23)
Proteinases and proteinase inhibitors in the fertilization process: new concepts of control? (1973) (23)
Monitoring of aprotinin plasma levels by an enzyme-linked immunosorbent assay (ELISA) (1984) (23)
Recombinant leech-derived tryptase inhibitor: construction, production, protein chemical characterization and inhibition of HIV-1 replication. (1994) (23)
A hirudin-sensitive, growth-related proteinase from human fibroblasts. (1998) (22)
Local serum application: restoration of sufficient host defense in human peritonitis (1994) (22)
B1 kinin receptor activity in pigs is associated with pre-existing infection. (1998) (21)
Inhibition of histamine release from human mast cells ex vivo by natural and synthetic chymase inhibitors. (1990) (21)
Characterization of the proteinase inhibitors from bull seminal plasma and spermatozoa. (1976) (21)
Proteolytic enzymes in yolk-sac membrane of quail egg. Purification and enzymatic characterisation. (1997) (21)
The isolation of tetrahydroxy bile acids as methyl esters from human urine and their characterization by 1H- and 13C-nuclear magnetic resonance spectroscopy. (1984) (20)
μ-Calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation (2006) (20)
Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor. (1999) (20)
Localization of Kallikrein in Porcine Pancreas and Submandibular Gland as Revealed by the Indirect Immunofluorescence Technique (1978) (20)
Effect of a serine proteinase inhibitor from Leucaena leucocephala on plasma kallikrein and plasmin. (1996) (20)
Electrostatic interactions of domain III stabilize the inactive conformation of mu-calpain. (2004) (20)
[Release of granulocytic elastase and plasma protein changes in traumatic hemorrhagic shock]. (1986) (19)
N-Terminal amino acid sequence of boar sperm acrosin. Homology with other serine proteinases. (1980) (19)
Evaluation of phage display system and leech-derived tryptase inhibitor as a tool for understanding the serine proteinase specificities. (2004) (19)
Leupeptin and antipain. Strong competitive inhibitors of sperm acrosomal proteinase (boar acrosin) and kallikreins from porcine organs (pancreas, submand. glands, urine). (1973) (19)
Expression and cellular localization of kininogens in the human kidney. (1996) (19)
Functional display and expression of chicken cystatin using a phagemid system. (1995) (18)
Expression levels strongly affect ligand-induced sequestration of B2 bradykinin receptors in transfected cells. (2003) (18)
Plasma levels of human granulocytic elastase-alpha1-proteinase inhibitor complex (E-alpha1PI) in patients with septicemia and acute leukemia (1983) (18)
Biochemical, Pharmacological, and Functional Aspects of Glandular Kallikreins (1980) (18)
Reduction of myocardial infarction by postischemic administration of the calpain inhibitor A-705253 in comparison to the Na+/H+ exchange inhibitor Cariporide® in isolated perfused rabbit hearts (2008) (18)
N α-Benzoyl-L-arginine Ethyl Ester Splitting Activity (Acrosin) in Human Spermatozoa and Seminal Plasma during Aging in Vitro (1975) (18)
Influence of chain shortening on the inhibitor properties of hirudin and eglin c. (1987) (17)
Possible involvement of kinins in muscle energy metabolism. (1984) (17)
Hirudin, a new therapeutic tool? (1991) (17)
Kinin receptors and angiotensin converting enzyme in rabbits basilar arteries (1983) (17)
Production, inhibitory activity, folding and conformational analysis of an N-terminal and an internal deletion variant of chicken cystatin. (1994) (16)
Localization of seminal plasma proteinase inhibitors in human spermatozoa as revealed by the indirect immunofluorescence technique. (1976) (16)
Structure, Biochemistry and Comparative Aspects of Mammalian Seminal Plasma Acrosin Inhibitors (1976) (16)
Eglin c, a pharmacologically active elastase inhibitor. (1985) (16)
Human kininogens and their function in the kallikrein-kinin systems. (1984) (16)
Trypsin-Plasmin Inhibitors from Leeches Isolation, Amino Acid Composition, Inhibitory Characteristics (1971) (15)
Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches. (1993) (15)
The Kallikrein-Kinin system and muscle metabolism: Biochemical aspects (1980) (15)
Plasma kallikrein localisation in human blood vessels. (1999) (15)
Human urinary kallikrein. (1981) (15)
The isolation and properties of pig submandibular kallikrein. (1979) (15)
Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B. (1996) (15)
Studies on the elimination of secretin and cholecystokinin with regard to the kinetics of exocrine pancreatic secretion. (1974) (14)
The mammalian cysteine proteinase inhibitors. Structural diversity and evolutionary origin (1986) (14)
Structural homology of a trypsin‐plasmin inhibitor from leeches (bdellin B‐3) with secretory trypsin inhibitors from mammals (1976) (14)
Pathobiochemistry of sepsis: role of proteinases, proteinase inhibitors and oxidizing agents. (1986) (14)
Kininogenases, Kininases, and Their Inhibitors (1966) (14)
Immunological similarity between low molecular weight trypsin-chymotrypsin inhibitors from human bronchial secretion and seminal plasma. (1976) (13)
An enzymatic assay convenient for the control of aprotinin levels during proteinase inhibitor therapy (1984) (13)
Kinetics of exocrine pancreatic secretion. (1972) (13)
Structure-based Design of a Potent Chimeric Thrombin Inhibitor* (1997) (13)
[Human acrosin: inhibition by protein-proteinase inhibitors]. (1972) (13)
Occurrence of multiple forms of bull and ram acrosin during proenzyme activation and inhibition of activation by p-nitrophenyl p'-guanidinobenzoate. (1976) (13)
Interactions of boar acrosin with detergents. (1980) (12)
Elastase and its Inhibitors in Intensive Care Medicine (1990) (12)
Pharmacokinetics, effect on clotting tests and assessment of the immunogenic potential of hirudin after a single subcutaneous or intravenous bolus administration in man. (1991) (12)
Oligomerisation of boar acrosin. (1980) (11)
[76] Proteinase (elastase) inhibitors from dog submandibular glands (1976) (11)
Purification, Characterization, and Structural Studies of Proteinase Inhibitors from Boar Seminal Plasma and Boar Spermatozoa (1974) (11)
Studies on the biological function of glandular kallikrein. (1979) (11)
Cleavage specificity of boar acrosin on polypeptide substrates, ribonuclease and insulin B-chain. (1975) (11)
Inhibition of proteinases with recombinant eglin C during experimental Escherichia coli septicemia in the pig. (1989) (11)
Time dependent release of tissue‐type plasminogen activator and plasminogen activator inhibitor into the circulation of pigs during shock (1991) (11)
Oxidative autoaggression by phagocytes in human peritonitis (1997) (11)
Quantitation of myeloperoxidase from human granulocytes as an inflammation marker by enzyme-linked immunosorbent assay (1986) (10)
Boar acrosin, I: modified isolation procedure, active-site titration and evidence for the presence of sialic acid. (1975) (10)
[73] Proteinase nhibitors from guinea pig seminal vesicles (1976) (10)
The Kallikrein-Kinin system and muscle metabolism—Clinical aspects (2005) (10)
Human leukocyte elastase inhibitors: designed variants of human pancreatic secretory trypsin inhibitor (hPSTI). (1990) (10)
Isolation of protease inhibitors. (1966) (10)
Quantitation of human lactoferrin as an inflammation marker by an enzyme-linked immunosorbent assay (ELISA) (1986) (9)
Endogenous B1 receptor mediated hypotension produced by contact system activation in the presence of endotoxemia. (1998) (9)
Structural aspects of human kininogens. (1983) (9)
Significance of Kinins in The Coronary Circulation (1969) (9)
Quantitation and differentiation of human kininogens by enzyme-linked immunosorbent assays (ELISA) (1984) (9)
Effect of the elastase inhibitor eglin C in porcine endotoxin shock. (1992) (8)
Inhibition of three porcine glandular kallikreins by chloromethyl ketones. (1977) (8)
Cysteine Proteinases and Their Inhibitors A Traditional Topic of the Portoroz Conferences (2001) (8)
Proteases as mediators of pulmonary vascular permeability. (1989) (8)
Proteinase Inhibitor Candidates for Therapy of Enzyme-Inhibitor Imbalances (1992) (8)
Proteinase inhibitor therapy of severe inflammation in pigs: First results with eglin, a potent inhibitor of granulocyte elastase and cathepsin G. (1986) (8)
Cystatins as Calpain Inhibitors: Engineered Chicken Cystatin- and Stefin B-Kininogen Domain 2 Hybrids Support a Cystatin-Like Mode of Interaction with the Catalytic Subunit of µ-Calpain (2001) (8)
Bradykinin-induced tyrosine phosphorylation of proteins in cultured human keratinocytes. (1998) (7)
The effect of kinins on paw oedema and uterus in rats (1984) (7)
[Isolation and characterization of sialic acid-rich and sialic acid-free kallikrein from porcine pancreas]. (1967) (7)
Peptidases, proteinases and their inhibitors (1984) (7)
Human urinary kallikrein—Biochemistry and physiological studies (1980) (7)
[On protease inhibitors, V. On the chemistry and physiology of the specific trypsin inhibitors from the ox, dog, pig and human pancreas]. (1967) (7)
Proteinases and their inhibitors in inflammation (1983) (7)
Proteinase inhibitors from guinea pig seminal vesicles. (1976) (7)
[On protease inhibitors. IV. Isolation of protease inhibitors with the aid of water insoluble enzyme resins]. (1967) (7)
Balanced antiinflammation: the combined application of a PAF inhibitor and a cyclooxygenase inhibitor blocks the inflammatory take-off after burns. (1990) (6)
Boar acrosin, II: Amino acid composition, amino terminal residue and molecular weight estimations by ultracentrifugation. (1975) (6)
Striking structural similarity of pig pancreatic kallikrein, mouse nerve growth factor gamma-subunit and rat tonin. (1981) (6)
[Distribution and excretion of naturally occurring and chemically modified protease inhibitors following intravenous injection in rats, dogs (and man)]. (1969) (6)
147 IMMUNOLOGICAL MONITORING OF NEW INFLAMMATORY PARAMETERS IN SEPSIS AND TRAUMA PATIENTS (1995) (5)
[On the presence of a trypsin-plasmin inhibitor in hirudin]. (1969) (5)
[Isolation of protease inhibitors by water-insoluble trypsin-cellulose resins]. (1970) (5)
Proteolytic Enzyme Systems (1993) (5)
A new, highly sensitive enzymic assay for human tryptase and its use for identification of tryptase inhibitors. (1990) (5)
Tachyphylaxis of the B1 kinin receptor in porcine endotoxin shock. (1997) (5)
Protein Proteinase Inhibitors in Male Sex Glands (1971) (5)
Detection of cathepsin B in tumor cytosol and urine of breast cancer patients. (1991) (5)
Human plasma kininogens are identical with α‐cysteine proteinase inhibitors (5)
Protein Proteinase Inhibitors in Male Sex Glands and their Secretions (1973) (5)
Kallikrein-related peptidases: Novel cancer-related biomarkers (2012) (5)
Kallikrein-related peptidases: Characterization, regulation, and interactions within the protease web (2012) (5)
[Identity of progressive antikallikrein with alpha1-antitrypsin from human serum]. (1969) (4)
Isolation of porcine urinary kallikrein. (1976) (4)
Granulocyte proteinases as maediators of unspecific proteolysis in inflammation (1984) (4)
[Use of water-insoluble derivatives of the trypsin-kallikrein inhibitor for the isolation of kallikrein and plasmin]. (1969) (4)
Glandular and plant kallikrein inhibitors (1975) (4)
[New polyvalent protease inhibitors for trypsin, chymotrypsin, plasmin and kallikreins from snails (Helix pomatia)]. (1972) (4)
Proteinase Inhibitors from Dog Submandibular Glands — Isolation, Amino Acid Composition, Inhibition Spectrum (1971) (4)
Aprotinin and its target enzymes in vitro and in vivo (1990) (4)
Determination of bradykinin, kallidin and Met-Lys-bradykinin by high performance liquid chromatography. (1982) (4)
[Isolation of a trypsin-like enzyme (acrosin) from boar spermatozoa]. (1972) (4)
Proteinase inhibitors : proceedings of the 2nd international research conference (1974) (4)
Specific Isolation and Modification Methods for Proteinase Inhibitors and Proteinases (1971) (4)
Naturally occurring low molecular weight inhibitors of neutral proteinases from PMN-granulocytes and of kallikreins (2005) (3)
Isolation of porcine submaxillary kallikrein. (1976) (3)
[Protease inhibitors in human sperm plasma. Isolation using affinity chromatography and inhibition characteristics]. (1971) (3)
Intra-peritoneal aprotinin therapy for acute pancreatitis. Preliminary pharmacodynamic studies. (1988) (3)
SPERM PROTEINASES AND THEIR INHIBITORS (1978) (3)
Isolation of Proteinases and Proteinase Inhibitors by Affinity Chromatography on Cellulose Matrices (1974) (3)
Activation of chymotrypsinogen by boar acrosin and its prevention by antiboar acrosin rabbit gamma-globulins. (1976) (3)
Proceedings of the International Research Conference on Proteinase Inhibitors, Munich, November 4-6, 1970 (1971) (3)
Proteinases and their inihibitors in septicemia (1984) (3)
[The isolation of porcine and human kallikrein using affinity chromatography: specific binding to water-insoluble Kunitz soybean-inhibitor-celluloses and dissociation with competitive inhibitors (benzamidine)]. (1972) (3)
Biochemical properties and possible therapeutic role of the elastase inhibitor eglin C. (1985) (3)
Highlight: the 4th International Symposium on Kallikreins and Kallikrein-related peptidases. (2012) (2)
Elastase-alpha1-proteinase inhibitor complex (1984) (2)
[Concentration of low-molecular protease inhibitor in the bronchial secretion in 1 -antitrypsin deficiency]. (1972) (2)
A Kazal-Type Inhibitor of Human Mast Cell Tryptase (1997) (2)
Differential patterns of PMN-elastase and type III procollagen peptide in knee joint effusions due to acute and chronic sports injuries (1991) (2)
Phagocyte Proteinases in Multiple Trauma and Sepsis: Pathomechanisms and Related Therapeutic Approaches* (2019) (2)
[Isolation and trypsin inhibitors and trypsin-plasmin-inhibitors from the seminal vesicles of guinea pigs]. (1970) (2)
Proteinase (elastase) inhibitors from dog submandibular glands. (1976) (2)
Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxaemia) (1980) (2)
[Captopril in hypertensive patients with type II diabetes mellitus]. (1987) (2)
Proteinases as Mediators of the Disturbance of Pulmonary Vascular Permeability in Sepsis, Polytrauma, and ARDS (1992) (2)
Pathophysiology and Pathobiochemistry of Sepsis and Septic Shock (1982) (2)
Competitive antagonists of bradykinin: in vitro (jugular vein) and in vivo (blood pressure response) studies. (1989) (2)
[ -Antitrypsin and c 1-inactivator: progressive inhibitors of human and porcine kallikrein]. (1972) (1)
[Characterization of a trypsin-like proteinase (acrosin) from boar spermatozoa by inhibition with different protein proteinase ingibitors, I: Seminal trysin inhibitors and the trypsin-kallikrein inhibitor from bovine organs]. (1972) (1)
[Identification of lysine and arginine residues as inhibitory centers of protease inhibitors by means of maleic anhydride and butane-(2.3)-dione]. (1969) (1)
Evaluation of the kinin-induced pathomechanisms in the development of ARDS by kallikrein inhibition in vivo. (1987) (1)
[Pathobiochemistry of selected plasma proteins]. (1983) (1)
Released Granulocytic Elastase (1985) (1)
Introduction to Volume 2: Kallikrein-related Peptidases. Novel Cancer-related Biomarkers (2012) (1)
Vito Turk--30 years of research on cysteine proteases and their inhibitors. (2003) (1)
Spermatozoa Acrosin and Seminal Plasma Acosin Inhibitors (1978) (1)
[On protease inhibitors, VI. On the identity of the protease inhibitor from rat liver with the trypsin-kallikren-inhibitor (Trasylol]. (1967) (1)
Enhancement of sperm acrosin activity by glycerol-pretreatment — quantitative estimations (1976) (1)
[Identity of the polyvalent protease inhibitor from sheep lung with the trypsin-kallikrein inhibitor from bovine organs]. (1970) (1)
[Characterization of a trypsin-like proteinase (acrosin) from boar spermatozoa by inhibition with different protein proteinase inhibitors. 3. Inhibitors from pancreas glands]. (1972) (1)
[On the primary structure of the specific trypsin inhibitor from sheep pancreas]. (1969) (1)
Proteases and Their Inhibitors: Traditional Research Subjects in the Munich Area (2002) (1)
Kallikreins and kallikrein-related peptidases (2008) (1)
[Use of water-insoluble enzyme resins with polyanionic and polyamphoteric resin matrices for the isolation of protease inhibitors]. (1969) (1)
Coagulation Defects Due To Inactivation Of Plasma Inhibitors By Granulocytic Elastase (1981) (1)
[The isolation of organ and urinary kallikreins using affinity chromatography: specific binding to water-insoluble inhibitor derivatives and the dissociation of the complexes with competitive inhibitors (benzamidine)]. (1972) (1)
[Preparation and properties of active derivatives of the trypsin-kallikrein inhibitor from bovine organs]. (1969) (1)
[On the secretory activity of specific trypsin inhibitors and kallikreinogen in the canine and human pancreas]. (1967) (1)
[Fixation and alteration of a protease inhibitory substance in the kidney]. (1969) (1)
Notice on Short Communications (1974) (1)
Human b-tryptase isa ring-like tetramerwithactive sites facingacentral pore (1)
[Characterization of a trypsin-like proteinase (acrosin) from boar spermatozoa by inhibition with different protein proteinase inhibitors, II. Inhibitors from leeches, soybeans, peanuts, bovine colostrum and sea anemones]. (1972) (1)
[The amino acid sequence of the double-headed protein proteinase inhibitor from dog submandibular glands, I. Structural homology to the pancreatic secretory trypsin inhibitors (author's transl)]. (1975) (1)
Introduction to Volume 1: Kallikrein-related Peptidases. Characterization, Regulation, and Interactions Within the Protease Web (2012) (1)
Lysosomal and system-specific proteinases as inflammatory mediators (1986) (1)
Influence of boar acrosin antibodies produced in rabbit and sheep on chymotrypsinogen activation catalyzed by acrosin from boar, bull, ram, rabbkt and human. (1976) (1)
Kallikreins, Kinins and Allergy (1981) (1)
in press-uncorrected proof m-Calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca 2 H-activated conformation (2006) (1)
[Possibilities of biochemical differentiation of reactive effusions of the knee joint]. (1987) (1)
Plasma levels of neutrophil elastase-Alpha1-proteinase inhibitor complexes and factor XIII (including subunits A and S) in septicemia and leucemia (1983) (1)
[Identification of a methionine residue as the reactive site for chymotrypsin in the double-headed proteinase inhibitor from the canine submandibular gland (author's transl)]. (1975) (0)
Vito Turk--a proactive catalyst not only in the field of cysteine proteinases and their inhibitors. (1998) (0)
Modulation of resynthesis of 1-alkyl-2-arachidonyl-glycero-3-phosphocholine and phosphatidylinositols for interception in vivo of free arachidonic acid, lyso-PAF, diacyl-glycerols, and phosphoinositides. (1989) (0)
[On the structure of papulacandin B, a new antibiotic with antifungal activity (author's transl)]. (1977) (0)
Hirudins: Structure-function relationships — behavior and effects in in vivo-models (1987) (0)
Clinical relevance of monitoring plasma levels of proteinases, proteinase inhibitors, and cytokines in the course of multiple organ failure (1992) (0)
Biochemical , Pharmacological , and Functional Aspects of Glandular (2009) (0)
Calpain μ Subunit Interactions of Ubiquitous in Vivo Subcellular Localization and REGULATION (2014) (0)
[Polyvalent protease inhibitors in sea anemones (Actinaria) with an inhibition spectrum analogous to that of the trypsin-kallikrein inhibitor from bovine organs]. (1972) (0)
Functional Anatomy of Acrosin Inhibitors (1975) (0)
The role of the Kallikrein-Kinin system for hormonal and metabolic regulation (1980) (0)
[Isolation of the trypsin inhibitor from sheep pancreas and its behavior toward proteolytic enzymes]. (1970) (0)
Hirudin pa and its derivatives, processes for their preparation and their use. (1985) (0)
RELATIONS BETWEEN APROTININ CONCENTRATIONS AND HEMODYNAMICS IN EXPERIMENTAL ACUTE PANCREATITIS (1987) (0)
[Preparation of modified protease inhibitors using water-insoluble trypsin resins]. (1970) (0)
8th Winter School on Proteinases and their Inhibitors : recent developments, Tiers, March 8-12, 1989 (1989) (0)
834 NATURALLY OCCURRING PROTEASE INHIBITORS [ 741 [ 74 ] Proteinase Inhibitors from Boar Seminal Plasma (2009) (0)
Determination of the molecular weights of new trypsin inhibitors using Sephadex gel filtration (1965) (0)
[Human acrosin: isolation and properties]. (1972) (0)
Functional determination of tPA, PAI and fibrinogen in endotoxin shock of the pig. (1989) (0)
Isolation of porcine submandibular kallikrein (1976) (0)
Quantification of granulocyte enzymes/proteins with immunoassays. (1987) (0)
[The selective binding of alpha1-antitrypsin to trypsin- and chymotrypsin-cellulose. Demonstration of complexes between alpha1-antitrypsin and proteases in blood serum (author's transl)]. (1973) (0)
Desulphatohirudins and their pharmaceutically acceptable salts, their preparation, pharmaceutical composition containing these compounds and the use of the compounds for the manufacture of pharmaceutical agent and as an analytical reagent (1984) (0)
High Affinity Binding and Direct Antiproliferative Effects of LHRH Analogues in Human Ovarian Cancer Cell Lines 1 ' 2 (2006) (0)
Highlight: 29 th Winter School on Proteinases and Their Inhibitors. (2012) (0)
Modified protease inhibitors, processes for their production, and it was preparing pharmaceutical products (1983) (0)
ROLE OF BRADYKININ AND MECHANISMS OF ACTION IN PULMONARY AND SYSTEMIC EDEMA FORMATION: 182A (1999) (0)
Modified egliner B and C, their use as protease inhibitors, processes for their preparation and pharmaceutical compositions containing the modified egliner b and c (1984) (0)
Seminal and Cervical Acid Stable Proteinase Inhibitors and Sperm Acrosin (1975) (0)
Proteinase inhibitors, processes for their preparation and pharmaceutical compositions containing them. (1990) (0)
Isolation and Characterization of Porcine α1-Proteinase Inhibitor. Leukocyte Elastase-Inhibitor Complexes in Porcine Blood, I. (1985) (0)
[Determination of the half life time of secretin]. (1969) (0)
[Postreceptor defect in the effectiveness of insulin: significance of the kallikrein-kinin-prostaglandin system]. (1986) (0)
Desulphatohirudins as well as their preparation and use (1984) (0)
[Characterization of a trypsin-like proteinase--acrosion--from boar sperm by inhibition with various protein-proteinase inhibitors. I. Seminal trypsin inhibitors and the trypsin-kallikrein inhibitor from bovine organs] (1972) (0)
[On the problem of the trypsin-inhibiting effect of the duodenal juice]. (1965) (0)
Guest Editorial Protease Inhibitors (2006) (0)
Proteinase Inhibitors from Dog Submandibular Glands (1971) (0)
[Characterization of porcine and human serum kallikrein using inhibition through protein-proteinase inhibitors]. (1972) (0)
Kallikrein inhibitors 1 (2009) (0)
Hirudin-PA, desulphatohirudins-pa, process for preparing and pharmaceutical compositions containing these active substances (1984) (0)
Variants of human seminal acrosin inhibitor (HUSI-II) which inhibit human leukocyte elastase. (1991) (0)
Subject Index, Vol. 21, 1991 (1991) (0)
Elastase-alpha1-Proteinaseinhibitor-Komplex (E-alpha1PI) (1983) (0)
A new highly sensitive assay of human mast cell tryptase and its use for characterization of tryptase inhibitors (1990) (0)
Proteinase Inhibitors and Biological Control – An Attractive International Symposia Series (2007) (0)
The E.K. Frey-E. Werle Foundation of the Henning L. Voigt Family (1992) (0)
In memoriam Kanti D. Bhoola (1930–2019) (2020) (0)
Phagocyte proteinases in multiple trauma and sepsis (1993) (0)
Proteinase-proteinase inhibitor imbalance in inflammation and multiple trauma with special amphasis on release of granulocytic lysosomal elastase (1984) (0)
A process for the concentration of the inhibitors of kallikrein, trypsin, plasmin and chymotrypsin. (1967) (0)
Proteinases and Proteinase Inhibitors in Fertilization (1976) (0)
Biochemistry and molecular biology of the kallikrein-kinin system (1992) (0)
Targets for antienzymatic contraception (1971) (0)
The tangled web (1990) (0)
Local serum application (1994) (0)
Robert Huber--a life devoted to protein structures and functions. (1997) (0)
The Frey-Werle Foundation award ceremony, Friday, October 23, 1998, Noh Hall, Nara New Public Hall. (1999) (0)
The 3(rd) International Symposium on Kallikreins and Kallikrein-Related Peptidases. (2010) (0)
198 DEXTRAN SULFATE ACTIVATES THE CONTACT SYSTEM AND MEDIATES ARTERIAL HYPOTENSION VIA B2 KININ RECEPTORS (1995) (0)
[ENZYME INHIBITORS OF THE EXOCRINE PANCREAS]. (1964) (0)
[Behavior of chymotrypsin-like proteinase from human spermatozoa towards protein-proteinase inhibitors]. (1972) (0)
Pathobiochemical mechanisms leading to acquired coagulation defects (1985) (0)
Editorial: Cysteine Proteinases and Their Inhibitors - A Traditional Topic of the Portoroz Conferences (2001) (0)
Clotting and other plasma factors in septicemia (1980) (0)
[Properties of the trypsin-like (acrosin) from boar spermatozoa]. (1972) (0)
Highlight: The Winter School on Proteinases and Their Inhibitors (2011) (0)
Highlight: 29th Winter School on Proteinases and Their Inhibitors (2011) (0)
Biological Functions of Proteases and Inhibitors / Preface /Foreword / Contents (1994) (0)
Desulfatohirudins, methods for their manufacture, pharmaceutical products. (1983) (0)
Metallocarboxypeptidases inhibitor as fibrinolytic agent. (1998) (0)
Protease inhibitors, processes for their preparation and medicines containing them (1990) (0)
THE STRUCTURE OF PAPULACANDIN B, A NEW ANTIBIOTIC WITH ANTIFUNGAL ACTIVITY (1977) (0)
Desulphatohirudins process for their preparation and pharmaceutical compositions (1984) (0)
Isolation of porcine urinary kallikrein (1976) (0)
Pathomechanismus in Septic Shock (1986) (0)
[Hyperdynamic septic shock in man: concentration course of selected coagulation factors and plasma proteins]. (1979) (0)
Boar and Human Acrosin and Acrosin Inhibitors (1973) (0)
Pathobiochemistry of Sepsis (1986) (0)
Modified hirudins, process for their preparation, pharmaceutical products containing these active substances (1985) (0)
405 Inhibition of fibrinolysis in endotoxin shock of the pig (1988) (0)
Title Page / Table of Contents, Vol. 21, Supplement 1, 1991 (1991) (0)
The Kallikrein-Kinin System and Muscle Metabolism : Biochemical Aspects by GI 3 (0)

This paper list is powered by the following services:

Hans Fritz's Academic­Influence.com Rankings

Why Is Hans Fritz Influential?

Hans Fritz's Published Works

Published Works

Hans Fritz's AcademicInfluence.com Rankings